Free Trial
→ I'm handing you this one free (From Behind the Markets) (Ad)tc pixel Free CBLL Stock Alerts

CeriBell (CBLL) Financials

CeriBell logo
$26.14 -0.21 (-0.80%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$26.16 +0.02 (+0.06%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for CeriBell

Annual Income Statements for CeriBell

This table shows CeriBell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -29 -40 -53
Consolidated Net Income / (Loss)		 -29 -40 -53
Net Income / (Loss) Continuing Operations		 -29 -40 -53
Total Pre-Tax Income 		-29 -40 -53
Total Operating Income		 -30 -40 -58
Total Gross Profit		 38 57 78
Total Revenue		 45 65 89
Operating Revenue		 45 65 89
Total Cost of Revenue		 7.06 8.69 11
Operating Cost of Revenue		 7.06 8.69 11
Total Operating Expenses		 68 96 137
Selling, General & Admin Expense		 20 34 44
Marketing Expense		 39 49 73
Research & Development Expense		 9.00 14 19
Total Other Income / (Expense), net		 0.59 -0.75 4.99
Interest Expense		 2.10 1.99 1.89
Other Income / (Expense), net		 2.69 1.25 6.88
Income Tax Expense		 0.01 0.00 0.00
Basic Earnings per Share		 ($5.56) ($3.39) ($1.46)
Weighted Average Basic Shares Outstanding		 5.30M 11.95M 36.54M
Diluted Earnings per Share		 ($5.56) ($3.39) ($1.46)
Weighted Average Diluted Shares Outstanding		 5.30M 11.95M 36.54M
Weighted Average Basic & Diluted Shares Outstanding		 - 35.87M 37.64M

Quarterly Income Statements for CeriBell

This table shows CeriBell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20 -19 -21
Consolidated Net Income / (Loss)		 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20 -19 -21
Net Income / (Loss) Continuing Operations		 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20 -19 -21
Total Pre-Tax Income 		-8.52 -8.94 -10 -13 -13 -14 -13 -14 -20 -19 -21
Total Operating Income		 -8.45 -8.44 -9.94 -13 -14 -15 -15 -15 -21 -20 -21
Total Gross Profit		 12 13 15 16 18 19 20 22 23 26 26
Total Revenue		 14 15 17 19 20 21 23 25 26 28 29
Operating Revenue		 14 15 17 19 20 21 23 25 26 28 29
Total Cost of Revenue		 2.06 2.16 2.18 2.30 2.48 2.52 2.65 3.14 3.37 2.16 3.00
Operating Cost of Revenue		 2.06 2.16 2.18 2.30 2.48 2.52 2.65 3.14 3.37 2.16 3.00
Total Operating Expenses		 21 22 25 29 32 34 35 36 44 46 47
Selling, General & Admin Expense		 7.24 7.61 9.03 9.97 9.94 11 11 12 15 15 14
Marketing Expense		 11 11 13 15 18 17 19 19 22 24 25
Research & Development Expense		 2.98 3.27 3.40 3.91 4.25 4.85 4.98 5.06 6.16 6.75 7.40
Total Other Income / (Expense), net		 -0.07 -0.51 -0.48 0.31 1.43 1.31 1.18 1.07 1.01 0.71 -0.80
Interest Expense		 0.44 0.53 0.53 0.50 0.47 0.48 0.48 0.46 0.43 0.44 0.27
Other Income / (Expense), net		 0.37 0.02 0.05 0.81 1.90 1.79 1.66 1.53 1.44 1.15 -0.54
Income Tax Expense		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Basic Earnings per Share		 ($1.56) ($1.61) ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52) ($0.51) ($0.55)
Weighted Average Basic Shares Outstanding		 5.46M 5.56M 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M 38.03M 38.50M
Diluted Earnings per Share		 ($1.56) ($1.61) ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52) ($0.51) ($0.55)
Weighted Average Diluted Shares Outstanding		 5.46M 5.56M 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M 38.03M 38.50M
Weighted Average Basic & Diluted Shares Outstanding		 - - 35.82M 35.87M 36.14M 36.66M 37.10M 37.64M 37.94M 38.38M 38.84M

Annual Cash Flow Statements for CeriBell

This table details how cash moves in and out of CeriBell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -34 160 -154
Net Cash From Operating Activities		 -29 -35 -41
Net Cash From Continuing Operating Activities		 -29 -35 -41
Net Income / (Loss) Continuing Operations		 -29 -40 -53
Consolidated Net Income / (Loss)		 -29 -40 -53
Depreciation Expense		 0.85 1.14 1.34
Amortization Expense		 0.36 0.38 -1.60
Non-Cash Adjustments To Reconcile Net Income		 2.02 6.47 12
Changes in Operating Assets and Liabilities, net		 -2.92 -2.58 1.35
Net Cash From Investing Activities		 -1.76 -1.60 -118
Net Cash From Continuing Investing Activities		 -1.76 -1.60 -118
Purchase of Property, Plant & Equipment		 -0.98 -1.34 -0.77
Purchase of Investments		 - 0.00 -211
Sale and/or Maturity of Investments		 - 0.00 94
Other Investing Activities, net		 -0.78 -0.26 -0.76
Net Cash From Financing Activities		 -2.82 197 5.05
Net Cash From Continuing Financing Activities		 -2.82 197 5.05
Repayment of Debt		 -3.75 -0.30 -0.15
Repurchase of Preferred Equity		 0.00 -5.05 0.00
Issuance of Debt		 0.00 7.91 0.00
Issuance of Common Equity		 - 1.13 5.44
Other Financing Activities, net		 0.93 193 -0.24
Cash Interest Paid		 1.73 1.95 1.89

Quarterly Cash Flow Statements for CeriBell

This table details how cash moves in and out of CeriBell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents		 -2.00 -8.13 -10 180 -41 -113 -16 17 4.78 -13 9.33
Net Cash From Operating Activities		 -9.55 -6.98 -8.54 -9.98 -11 -7.53 -11 -11 -19 -13 -13
Net Cash From Continuing Operating Activities		 -9.55 -6.98 -8.54 -9.98 -11 -7.53 -11 -11 -19 -13 -13
Net Income / (Loss) Continuing Operations		 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20 -19 -21
Consolidated Net Income / (Loss)		 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20 -19 -21
Depreciation Expense		 0.26 0.28 0.24 0.36 0.34 0.32 0.39 0.29 0.24 0.25 0.25
Amortization Expense		 0.09 0.11 0.09 0.09 0.08 -0.37 -0.80 -0.52 -0.56 -0.54 -0.26
Non-Cash Adjustments To Reconcile Net Income		 0.79 1.23 1.45 2.89 1.92 3.24 3.08 3.27 3.83 6.55 8.63
Changes in Operating Assets and Liabilities, net		 -2.16 0.35 0.09 -0.74 -0.97 2.91 -0.30 -0.30 -3.07 0.15 -0.35
Net Cash From Investing Activities		 -0.13 -1.16 0.18 -0.49 -30 -108 -6.94 26 22 -0.61 21
Net Cash From Continuing Investing Activities		 -0.13 -1.16 0.18 -0.49 -30 -108 -6.94 26 22 -0.61 21
Purchase of Property, Plant & Equipment		 -0.10 -0.32 -0.57 -0.36 -0.15 -0.07 -0.37 -0.18 -0.13 -0.02 -0.10
Purchase of Investments		 0.00 - - - -29 -113 -46 -22 -27 -49 -13
Sale and/or Maturity of Investments		 - - - - 0.00 - 40 49 50 49 34
Other Investing Activities, net		 -0.04 -0.84 0.75 -0.14 -0.13 -0.16 -0.09 -0.37 -0.70 -0.21 -0.66
Net Cash From Financing Activities		 7.68 -0.00 -1.89 191 0.00 2.01 1.64 1.40 1.63 0.88 1.58
Net Cash From Continuing Financing Activities		 7.68 -0.00 -1.89 191 0.00 2.01 1.64 1.40 1.63 0.88 1.58
Repayment of Debt		 -0.35 0.04 - - -0.15 - - - 0.00 - -42
Issuance of Debt		 7.91 - - - 0.00 - - - 0.00 - 40
Issuance of Common Equity		 0.12 0.49 0.33 0.19 0.15 2.01 1.64 1.64 1.63 0.88 3.53
Cash Interest Paid		 0.39 0.53 0.27 0.76 0.47 0.48 0.48 0.46 0.43 0.44 0.27

Annual Balance Sheets for CeriBell

This table presents CeriBell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 59 225 196
Total Current Assets		 52 217 187
Cash & Equivalents		 34 194 40
Short-Term Investments		 - 0.00 119
Accounts Receivable		 7.96 11 15
Inventories, net		 5.87 6.94 7.29
Prepaid Expenses		 2.13 3.25 2.91
Other Current Assets		 1.52 1.84 2.21
Plant, Property, & Equipment, net		 1.58 2.31 2.03
Total Noncurrent Assets		 5.38 5.83 7.06
Other Noncurrent Operating Assets		 5.38 5.83 7.06
Total Liabilities & Shareholders' Equity		 59 225 196
Total Liabilities		 24 34 40
Total Current Liabilities		 22 13 19
Accounts Payable		 0.73 1.14 2.84
Accrued Expenses		 7.54 10 14
Current Deferred Revenue		 - 0.10 0.10
Other Current Liabilities		 1.50 1.70 1.92
Total Noncurrent Liabilities		 2.16 21 21
Long-Term Debt		 0.00 20 20
Other Noncurrent Operating Liabilities		 2.16 1.67 1.47
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -112 191 155
Total Preferred & Common Equity		 -112 191 155
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 -112 191 155
Common Stock		 14 358 376
Retained Earnings		 -126 -167 -220
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 0.16

Quarterly Balance Sheets for CeriBell

This table presents CeriBell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets		 47 213 208 200 178 166 156
Total Current Assets		 35 205 200 192 169 158 147
Cash & Equivalents		 14 153 40 24 45 33 42
Short-Term Investments		 - 29 137 145 96 97 75
Accounts Receivable		 9.97 11 12 12 16 16 18
Inventories, net		 6.91 6.55 6.00 6.02 6.90 6.74 6.96
Prepaid Expenses		 2.27 2.85 2.02 2.86 2.88 3.66 2.99
Other Current Assets		 1.70 2.02 2.02 2.15 2.23 2.20 2.23
Plant, Property, & Equipment, net		 2.27 2.13 2.11 2.06 1.93 1.76 1.77
Total Noncurrent Assets		 9.83 5.93 5.80 5.66 7.24 6.74 7.16
Other Noncurrent Operating Assets		 9.83 5.93 5.80 5.66 7.24 6.74 7.16
Total Liabilities & Shareholders' Equity		 47 213 208 200 178 166 156
Total Liabilities		 36 33 36 35 37 38 39
Total Current Liabilities		 13 12 15 15 16 17 18
Accounts Payable		 2.78 1.37 2.44 2.18 1.98 3.19 2.33
Accrued Expenses		 8.57 8.30 10 11 13 12 14
Current Deferred Revenue		 - 0.20 0.22 0.14 0.09 0.01 0.23
Other Current Liabilities		 1.74 1.96 1.93 1.94 1.55 1.52 1.41
Total Noncurrent Liabilities		 23 21 21 20 21 21 21
Long-Term Debt		 19 20 20 20 20 20 20
Other Noncurrent Operating Liabilities		 3.04 1.13 0.83 0.53 1.16 0.85 0.80
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -136 181 172 164 141 128 118
Total Preferred & Common Equity		 -136 181 172 164 141 128 118
Preferred Stock		 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -136 181 172 164 141 128 118
Common Stock		 18 361 366 371 381 388 398
Retained Earnings		 -154 -180 -193 -207 -240 -259 -281
Accumulated Other Comprehensive Income / (Loss)		 - -0.01 0.01 0.14 0.02 -0.09 -0.14

Annual Metrics And Ratios for CeriBell

This table displays calculated financial ratios and metrics derived from CeriBell's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - -
Revenue Growth		 0.00% 44.71% 36.09%
EBITDA Growth		 0.00% -41.29% -40.17%
EBIT Growth		 0.00% -40.61% -33.95%
NOPAT Growth		 0.00% -32.18% -47.08%
Net Income Growth		 0.00% -37.30% -32.03%
EPS Growth		 0.00% 39.03% 56.93%
Operating Cash Flow Growth		 0.00% -20.18% -16.45%
Free Cash Flow Firm Growth		 0.00% 0.00% -27.69%
Invested Capital Growth		 0.00% 30.84% -2.86%
Revenue Q/Q Growth		 0.00% 0.00% 7.55%
EBITDA Q/Q Growth		 0.00% 0.00% -3.33%
EBIT Q/Q Growth		 0.00% 0.00% -1.96%
NOPAT Q/Q Growth		 0.00% 0.00% -3.02%
Net Income Q/Q Growth		 0.00% 0.00% -1.81%
EPS Q/Q Growth		 0.00% 0.00% -380.77%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -2.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 3.94%
Profitability Metrics		 - - -
Gross Margin		 84.38% 86.72% 87.89%
EBITDA Margin		 -57.81% -56.45% -58.14%
Operating Margin		 -66.43% -60.68% -65.57%
EBIT Margin		 -60.49% -58.77% -57.85%
Profit (Net Income) Margin		 -65.15% -61.82% -59.97%
Tax Burden Percent		 100.04% 100.00% 100.00%
Interest Burden Percent		 107.67% 105.18% 103.67%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -168.26% -192.69% -253.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 -131.03% -179.87% -245.64%
Return on Net Nonoperating Assets (RNNOA)		 84.46% 156.94% 222.79%
Return on Equity (ROE)		 -83.80% -35.75% -30.83%
Cash Return on Invested Capital (CROIC)		 0.00% -219.41% -250.72%
Operating Return on Assets (OROA)		 -46.43% -27.05% -24.46%
Return on Assets (ROA)		 -50.01% -28.46% -25.36%
Return on Common Equity (ROCE)		 267.54% -12.46% -30.83%
Return on Equity Simple (ROE_SIMPLE)		 26.25% -21.16% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -28 -41
NOPAT Margin		 -46.50% -42.47% -45.90%
Net Nonoperating Expense Percent (NNEP)		 -37.22% -12.82% -7.97%
Return On Investment Capital (ROIC_SIMPLE)		 20.94% -13.19% -23.34%
Cost of Revenue to Revenue		 15.62% 13.28% 12.11%
SG&A Expenses to Revenue		 44.86% 51.71% 49.91%
R&D to Revenue		 19.89% 20.72% 21.49%
Operating Expenses to Revenue		 150.81% 147.39% 153.46%
Earnings before Interest and Taxes (EBIT)		 -27 -38 -52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -26 -37 -52
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 1.62 5.16
Price to Tangible Book Value (P/TBV)		 0.00 1.62 5.16
Price to Revenue (P/Rev)		 3.99 4.73 9.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 24.41 8.22 41.67
Enterprise Value to Revenue (EV/Rev)		 6.75 2.05 7.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.34 0.10 0.13
Long-Term Debt to Equity		 0.00 0.10 0.13
Financial Leverage		 -0.64 -0.87 -0.91
Leverage Ratio		 1.68 1.26 1.22
Compound Leverage Factor		 1.80 1.32 1.26
Debt to Total Capital		 25.18% 9.28% 11.31%
Short-Term Debt to Total Capital		 25.18% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 9.28% 11.31%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 313.69% 0.00% 0.00%
Common Equity to Total Capital		 -238.87% 90.72% 88.69%
Debt to EBITDA		 -0.45 -0.53 -0.38
Net Debt to EBITDA		 0.87 4.73 2.69
Long-Term Debt to EBITDA		 0.00 -0.53 -0.38
Debt to NOPAT		 -0.56 -0.70 -0.48
Net Debt to NOPAT		 1.08 6.29 3.41
Long-Term Debt to NOPAT		 0.00 -0.70 -0.48
Altman Z-Score		 1.40 5.20 10.92
Noncontrolling Interest Sharing Ratio		 419.26% 65.13% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 2.41 16.73 9.73
Quick Ratio		 1.97 15.80 9.08
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -32 -40
Operating Cash Flow to CapEx		 -2,966.33% -2,615.15% -5,320.47%
Free Cash Flow to Firm to Interest Expense		 0.00 -15.89 -21.38
Operating Cash Flow to Interest Expense		 -13.90 -17.59 -21.59
Operating Cash Flow Less CapEx to Interest Expense		 -14.37 -18.26 -22.00
Efficiency Ratios		 - - -
Asset Turnover		 0.77 0.46 0.42
Accounts Receivable Turnover		 5.69 6.95 6.87
Inventory Turnover		 1.20 1.36 1.52
Fixed Asset Turnover		 28.68 33.65 41.01
Accounts Payable Turnover		 9.65 9.27 5.42
Days Sales Outstanding (DSO)		 64.20 52.52 53.14
Days Inventory Outstanding (DIO)		 303.29 268.80 240.62
Days Payable Outstanding (DPO)		 37.83 39.36 67.34
Cash Conversion Cycle (CCC)		 329.66 281.96 226.42
Capital & Investment Metrics		 - - -
Invested Capital		 12 16 16
Invested Capital Turnover		 3.62 4.54 5.53
Increase / (Decrease) in Invested Capital		 0.00 3.86 -0.47
Enterprise Value (EV)		 305 134 662
Market Capitalization		 180 309 801
Book Value per Share		 ($21.16) $5.34 $4.19
Tangible Book Value per Share		 ($21.16) $5.34 $4.19
Total Capital		 47 211 175
Total Debt		 12 20 20
Total Long-Term Debt		 0.00 20 20
Net Debt		 -23 -175 -139
Capital Expenditures (CapEx)		 0.98 1.34 0.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 7.70 9.91 8.27
Debt-free Net Working Capital (DFNWC)		 42 204 168
Net Working Capital (NWC)		 30 204 168
Net Nonoperating Expense (NNE)		 8.44 13 13
Net Nonoperating Obligations (NNO)		 -23 -175 -139
Total Depreciation and Amortization (D&A)		 1.21 1.52 -0.26
Debt-free, Cash-free Net Working Capital to Revenue		 17.03% 15.15% 9.28%
Debt-free Net Working Capital to Revenue		 93.30% 312.15% 188.10%
Net Working Capital to Revenue		 67.14% 312.15% 188.10%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 ($3.39) ($1.46)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 11.95M 36.54M
Adjusted Diluted Earnings per Share		 $0.00 ($3.39) ($1.46)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 11.95M 36.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 35.87M 37.64M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -28 -41
Normalized NOPAT Margin		 -46.50% -42.47% -45.90%
Pre Tax Income Margin		 -65.13% -61.82% -59.97%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -13.04 -19.31 -27.26
NOPAT to Interest Expense		 -10.02 -13.95 -21.63
EBIT Less CapEx to Interest Expense		 -13.51 -19.98 -27.67
NOPAT Less CapEx to Interest Expense		 -10.49 -14.63 -22.04
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for CeriBell

This table displays calculated financial ratios and metrics derived from CeriBell's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding		 0.00 0.00 - - 35,868,339.00 36,143,022.00 36,663,968.00 - 37,641,229.00 37,942,700.00 38,378,101.00
DEI Adjusted Shares Outstanding		 0.00 0.00 - - 35,868,339.00 36,143,022.00 36,663,968.00 - 37,641,229.00 37,942,700.00 38,378,101.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 - - -0.36 -0.38 -0.37 - -0.52 -0.51 -0.56
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 48.09% 0.00% 42.30% 38.42% 31.37% 33.72% 29.30% 32.54% 29.89%
EBITDA Growth		 0.00% 0.00% -51.59% 0.00% -53.60% -64.56% -40.17% -14.36% -65.07% -44.79% -57.54%
EBIT Growth		 0.00% 0.00% -51.59% 0.00% -52.19% -56.50% -31.33% -8.18% -56.86% -43.02% -62.37%
NOPAT Growth		 0.00% 0.00% -38.71% 0.00% -68.07% -77.26% -47.40% -13.29% -46.02% -33.63% -40.29%
Net Income Growth		 0.00% 0.00% -47.68% 0.00% -49.95% -52.59% -29.26% -7.56% -54.47% -41.23% -58.57%
EPS Growth		 0.00% 0.00% -40.15% 0.00% 76.92% 76.40% 80.00% -121.47% -44.44% -34.21% -48.65%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% -49.44% -19.40% -7.98% -29.92% -8.01% -69.23% -70.76% -17.84%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 63.32% 0.00% 41.36% 25.18% -119.84%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -9.12% -2.86% 9.82% 32.10% 31.31%
Revenue Q/Q Growth		 0.00% 6.35% 0.00% 7.79% 0.00% 3.46% 6.56% 9.72% 6.90% 6.05% 4.43%
EBITDA Q/Q Growth		 0.00% -3.71% 0.00% -21.64% 0.00% -11.10% -1.37% 0.75% -47.68% 2.55% -10.30%
EBIT Q/Q Growth		 0.00% -4.04% 0.00% -22.15% 0.00% -6.99% 1.37% -0.62% -47.75% 2.45% -11.97%
NOPAT Q/Q Growth		 0.00% 0.21% 0.00% -29.66% 0.00% -5.24% 2.04% 0.35% -42.13% 3.68% -2.84%
Net Income Q/Q Growth		 0.00% -4.93% 0.00% -20.73% 0.00% -6.78% 1.30% -0.46% -45.91% 2.38% -10.81%
EPS Q/Q Growth		 0.00% -3.21% 0.00% 188.11% 0.00% -5.56% 2.63% 5.41% -48.57% 1.92% -7.84%
Operating Cash Flow Q/Q Growth		 -43.07% 26.95% 0.00% -16.78% -14.32% 33.94% -47.33% 2.92% -79.11% 33.34% -1.67%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 100.00% 0.00% 10.34% 64.94% -11.82% -66.85% -14.40% -3.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -2.76% 0.00% -19.05% 6.08% 3.94% 23.04% -2.62% 5.45%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 85.71% 85.92% 87.30% 87.61% 87.88% 88.13% 88.28% 87.33% 87.27% 92.32% 89.77%
EBITDA Margin		 -53.75% -52.41% -57.50% -62.70% -58.02% -62.31% -59.28% -53.62% -74.07% -68.07% -71.89%
Operating Margin		 -58.70% -55.08% -57.79% -69.52% -69.33% -70.53% -64.84% -58.89% -78.30% -71.11% -70.03%
EBIT Margin		 -56.15% -54.93% -57.50% -65.16% -60.06% -62.11% -57.48% -52.72% -72.86% -67.02% -71.86%
Profit (Net Income) Margin		 -59.17% -58.38% -60.58% -67.85% -62.35% -64.36% -59.61% -54.58% -74.50% -68.58% -72.77%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 105.38% 106.28% 105.36% 104.13% 103.83% 103.62% 103.70% 103.54% 102.25% 102.33% 101.27%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -194.74% -390.11% -530.59% -234.19% -227.78% -279.05% -303.57% -301.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -192.70% -386.64% -526.56% -229.71% -225.67% -275.38% -299.61% -295.83%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 176.22% 348.59% 482.49% 187.69% 204.67% 243.42% 266.26% 258.70%
Return on Equity (ROE)		 0.00% 0.00% 0.00% -18.52% -41.52% -48.10% -46.49% -23.10% -35.64% -37.30% -42.80%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -193.55% 0.00% 0.00% 0.00% -250.72% -252.80% -320.58% -327.52%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% -30.00% -20.12% -23.15% -38.61% -22.29% -35.38% -36.54% -43.90%
Return on Assets (ROA)		 0.00% 0.00% 0.00% -31.24% -20.90% -23.99% -40.04% -23.08% -36.17% -37.39% -44.46%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% -6.46% -41.52% -48.10% -7.44% -23.10% -35.64% -37.30% -42.80%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% -24.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -5.92 -5.90 -6.96 -9.02 -9.94 -10 -10 -10 -15 -14 -14
NOPAT Margin		 -41.09% -38.55% -40.45% -48.66% -48.53% -49.37% -45.39% -41.23% -54.81% -49.78% -49.02%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 128.50% -2.03% -3.47% -4.03% -4.48% -2.11% -3.67% -3.96% -5.66%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -4.28% -4.96% -5.46% -5.58% -5.83% -9.03% -9.43% -10.46%
Cost of Revenue to Revenue		 14.29% 14.08% 12.70% 12.39% 12.12% 11.87% 11.72% 12.67% 12.73% 7.68% 10.23%
SG&A Expenses to Revenue		 50.24% 49.70% 52.51% 53.77% 48.48% 53.59% 48.86% 48.90% 57.81% 52.52% 49.26%
R&D to Revenue		 20.72% 21.35% 19.74% 21.11% 20.72% 22.89% 22.06% 20.42% 23.25% 24.01% 25.23%
Operating Expenses to Revenue		 144.41% 141.00% 145.09% 157.13% 157.21% 158.66% 153.12% 146.22% 165.57% 163.43% 159.80%
Earnings before Interest and Taxes (EBIT)		 -8.09 -8.41 -9.89 -12 -12 -13 -13 -13 -19 -19 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -7.74 -8.03 -9.89 -12 -12 -13 -13 -13 -20 -19 -21
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 1.62 3.81 3.95 2.58 5.16 4.90 5.77 7.99
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 1.62 3.81 3.95 2.58 5.16 4.90 5.77 7.99
Price to Revenue (P/Rev)		 0.00 0.00 0.00 4.73 9.64 8.78 5.11 9.00 7.26 7.25 8.64
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 19.81 8.22 29.56 36.23 17.93 41.67 29.12 33.12 41.93
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 2.05 7.36 6.74 3.31 7.43 5.99 6.18 7.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 1.71 0.10 0.11 0.11 0.12 0.13 0.14 0.16 0.17
Long-Term Debt to Equity		 0.00 0.00 1.71 0.10 0.11 0.11 0.12 0.13 0.14 0.16 0.17
Financial Leverage		 0.00 0.00 0.47 -0.91 -0.90 -0.92 -0.82 -0.91 -0.88 -0.89 -0.87
Leverage Ratio		 0.00 0.00 4.12 1.26 1.18 1.21 1.40 1.22 1.22 1.24 1.26
Compound Leverage Factor		 0.00 0.00 4.34 1.31 1.23 1.25 1.46 1.26 1.24 1.27 1.28
Debt to Total Capital		 0.00% 0.00% 63.04% 9.28% 9.78% 10.26% 10.74% 11.31% 12.39% 13.47% 14.54%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 63.04% 9.28% 9.78% 10.26% 10.74% 11.31% 12.39% 13.47% 14.54%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 476.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% -439.69% 90.72% 90.22% 89.74% 89.26% 88.69% 87.61% 86.53% 85.46%
Debt to EBITDA		 0.00 0.00 0.00 -0.53 -0.48 -0.43 -0.39 -0.38 -0.33 -0.31 -0.27
Net Debt to EBITDA		 0.00 0.00 0.00 4.73 3.97 3.41 2.97 2.69 2.04 1.67 1.33
Long-Term Debt to EBITDA		 0.00 0.00 0.00 -0.53 -0.48 -0.43 -0.39 -0.38 -0.33 -0.31 -0.27
Debt to NOPAT		 0.00 0.00 0.00 -0.70 -0.62 -0.54 -0.50 -0.48 -0.44 -0.41 -0.38
Net Debt to NOPAT		 0.00 0.00 0.00 6.29 5.12 4.34 3.75 3.41 2.67 2.23 1.84
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -0.70 -0.62 -0.54 -0.50 -0.48 -0.44 -0.41 -0.38
Altman Z-Score		 0.00 0.00 0.00 5.58 12.74 11.41 6.97 11.57 10.43 10.74 13.24
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 65.13% 0.00% 0.00% 83.99% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 0.00 2.67 16.73 17.36 13.31 12.65 9.73 10.44 9.18 8.18
Quick Ratio		 0.00 0.00 1.84 15.80 16.40 12.64 11.92 9.08 9.69 8.45 7.50
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -24 0.00 -28 -25 -8.72 -9.75 -16 -19 -19
Operating Cash Flow to CapEx		 -10,052.63% -2,173.21% 0.00% -2,794.12% -7,704.73% -10,609.86% -3,007.59% -6,018.99% -15,437.60% -75,664.71% -13,078.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -44.85 0.00 -58.90 -52.15 -18.17 -21.10 -37.49 -42.49 -71.80
Operating Cash Flow to Interest Expense		 -21.95 -13.21 0.00 -19.99 -24.21 -15.79 -23.12 -23.32 -44.46 -29.37 -48.98
Operating Cash Flow Less CapEx to Interest Expense		 -22.17 -13.82 0.00 -20.71 -24.52 -15.94 -23.89 -23.71 -44.75 -29.41 -49.36
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.46 0.34 0.37 0.67 0.42 0.49 0.55 0.61
Accounts Receivable Turnover		 0.00 0.00 0.00 6.95 6.33 6.29 7.46 6.87 7.04 7.20 7.24
Inventory Turnover		 0.00 0.00 0.00 1.36 1.39 1.58 1.54 1.52 1.74 1.78 1.80
Fixed Asset Turnover		 0.00 0.00 0.00 33.65 33.66 36.78 38.31 41.01 46.93 52.76 56.79
Accounts Payable Turnover		 0.00 0.00 0.00 9.27 6.66 3.88 4.01 5.42 6.97 4.02 5.17
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 52.52 57.65 58.05 48.94 53.14 51.85 50.67 50.40
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 268.80 262.26 230.99 237.37 240.62 210.29 205.36 202.92
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 39.36 54.83 93.97 90.99 67.34 52.37 90.71 70.60
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 281.96 265.09 195.06 195.32 226.42 209.77 165.32 182.72
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 0.00 17 16 18 14 15 16 20 19 20
Invested Capital Turnover		 0.00 0.00 0.00 4.00 8.04 10.75 5.16 5.53 5.09 6.10 6.15
Increase / (Decrease) in Invested Capital		 0.00 0.00 17 0.00 18 14 -1.53 -0.47 1.75 4.63 4.79
Enterprise Value (EV)		 0.00 0.00 333 134 526 522 274 662 569 630 842
Market Capitalization		 180 180 180 309 689 680 423 801 690 740 939
Book Value per Share		 $0.00 $0.00 ($24.13) $5.34 $5.04 $4.76 $4.48 $4.19 $3.74 $3.38 $3.06
Tangible Book Value per Share		 $0.00 $0.00 ($24.13) $5.34 $5.04 $4.76 $4.48 $4.19 $3.74 $3.38 $3.06
Total Capital		 0.00 0.00 31 211 200 192 184 175 161 148 138
Total Debt		 0.00 0.00 19 20 20 20 20 20 20 20 20
Total Long-Term Debt		 0.00 0.00 19 20 20 20 20 20 20 20 20
Net Debt		 0.00 0.00 5.39 -175 -163 -158 -149 -139 -121 -109 -97
Capital Expenditures (CapEx)		 0.10 0.32 0.00 0.36 0.15 0.07 0.37 0.18 0.13 0.02 0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 7.76 9.91 11 7.34 8.10 8.27 12 11 12
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 22 204 194 185 177 168 153 141 129
Net Working Capital (NWC)		 0.00 0.00 22 204 194 185 177 168 153 141 129
Net Nonoperating Expense (NNE)		 2.60 3.04 3.46 3.56 2.83 3.18 3.21 3.31 5.22 5.28 6.97
Net Nonoperating Obligations (NNO)		 0.00 0.00 5.39 -175 -163 -158 -149 -139 -121 -109 -97
Total Depreciation and Amortization (D&A)		 0.35 0.39 0.00 0.46 0.42 -0.04 -0.41 -0.22 -0.32 -0.30 -0.01
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 15.15% 15.22% 9.49% 9.78% 9.28% 12.14% 11.17% 10.98%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 312.15% 270.62% 238.66% 213.30% 188.10% 160.65% 137.94% 119.03%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 312.15% 270.62% 238.66% 213.30% 188.10% 160.65% 137.94% 119.03%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52) ($0.51) ($0.55)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M 38.03M 38.50M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52) ($0.51) ($0.55)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M 38.03M 38.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 35.82M 35.87M 36.14M 36.66M 37.10M 37.64M 37.94M 38.38M 38.84M
Normalized Net Operating Profit after Tax (NOPAT)		 -5.92 -5.90 -6.96 -9.02 -9.94 -10 -10 -10 -15 -14 -14
Normalized NOPAT Margin		 -41.09% -38.55% -40.45% -48.66% -48.53% -49.37% -45.39% -41.23% -54.81% -49.78% -49.02%
Pre Tax Income Margin		 -59.17% -58.38% -60.58% -67.85% -62.35% -64.36% -59.61% -54.58% -74.50% -68.58% -72.77%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -18.59 -15.93 -18.65 -24.20 -26.13 -27.60 -27.05 -28.28 -44.48 -42.99 -78.97
NOPAT to Interest Expense		 -13.60 -11.18 -13.12 -18.07 -21.11 -21.94 -21.36 -22.12 -33.46 -31.93 -53.87
EBIT Less CapEx to Interest Expense		 -18.81 -16.54 0.00 -24.92 -26.44 -27.75 -27.82 -28.67 -44.77 -43.03 -79.34
NOPAT Less CapEx to Interest Expense		 -13.82 -11.79 0.00 -18.79 -21.43 -22.09 -22.13 -22.50 -33.75 -31.97 -54.25
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

CeriBell’s revenue growth remains strong, but profitability and cash generation have not yet caught up. Quarterly revenue increased from $11.6 million in Q3 2023 to $28.1 million in Q2 2026. In the latest quarter, revenue rose 6.1% from $26.5 million in Q1 2026 and 32.5% from $21.2 million in Q2 2025. Gross profit reached $25.9 million, while the gross margin improved to approximately 92.3%, compared with 87.3% in Q1 and 88.1% in Q2 2025.

Despite the top-line expansion, CeriBell continues to report substantial operating losses. Q2 2026 operating expenses totaled $45.9 million, including $24.4 million of marketing expense, $14.8 million of selling, general and administrative expense, and $6.7 million of research and development expense. The company reported a net loss of $19.3 million, or $0.51 per diluted share, compared with a $19.7 million loss in Q1 2026 and a $13.6 million loss in Q2 2025.

Liquidity remains a key support for the business, although it has declined materially from early 2025. At June 30, 2026, CeriBell held $32.7 million in cash and $96.6 million in short-term investments, or approximately $129.3 million in combined liquid assets. The company also had $20.0 million of long-term debt. However, operating cash flow remained negative at $12.9 million in Q2 2026, following a $19.3 million outflow in Q1, suggesting that continued operating losses could materially reduce the cash reserve over time.

  • Revenue growth is accelerating. Quarterly revenue has more than doubled from $11.6 million in Q3 2023 to $28.1 million in Q2 2026, indicating continued commercial expansion.
  • Gross margins are improving. The latest gross margin of approximately 92.3% was the strongest in the provided period and suggests favorable product economics or a changing revenue mix.
  • Near-term liquidity is substantial. Cash and short-term investments totaled approximately $129.3 million at the end of Q2 2026, while total current liabilities were $17.2 million.
  • Debt levels appear manageable relative to liquid assets. Long-term debt was approximately $20.0 million, meaning CeriBell had considerably more cash and short-term investments than debt.
  • Investment activity is primarily treasury management. CeriBell purchased $48.9 million of investments and sold or received maturities of $48.5 million in Q2 2026, resulting in only a $0.6 million net investing cash outflow.
  • Accounts receivable have remained relatively controlled. Accounts receivable increased modestly to $16.0 million in Q2 2026 from $15.7 million in Q1, despite the quarter’s revenue growth.
  • Operating cash flow has been consistently negative. CeriBell has reported negative operating cash flow in every provided quarter, including outflows of $12.9 million in Q2 2026 and $19.3 million in Q1 2026.
  • Losses are growing faster than the company’s ability to control expenses. The Q2 2026 net loss of $19.3 million was substantially larger than the $12.6 million loss reported in Q1 2024 and the $13.6 million loss in Q2 2025.
  • Marketing spending is absorbing much of the gross profit. Q2 marketing expense of $24.4 million represented nearly 87% of quarterly revenue, contributing heavily to the $20.0 million operating loss.
  • Shareholder dilution is an ongoing risk. Weighted-average basic shares increased from approximately 5.3 million in Q3 2023 to 38.0 million in Q2 2026, while the company continued to raise cash through common equity issuance.
11/14/26 08:10 PM ETAI Generated. May Contain Errors.

CeriBell Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CeriBell's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

CeriBell's net income appears to be on a downward trend, with a most recent value of -$53.41 million in 2025, falling from -$29.46 million in 2023. The previous period was -$40.46 million in 2024. Check out CeriBell's forecast to explore projected trends and price targets.

CeriBell's total operating income in 2025 was -$58.40 million, based on the following breakdown:
  • Total Gross Profit: $78.27 million
  • Total Operating Expenses: $136.68 million

Over the last 2 years, CeriBell's total revenue changed from $45.23 million in 2023 to $89.06 million in 2025, a change of 96.9%.

In the past 8 quarters, CeriBell's cash and equivalents has ranged from $14.11 million in Q3 2024 to $153.36 million in Q1 2025, and is currently $41.99 million as of their latest financial filing in Q3 2026.

CeriBell had total debt of $19.81 million at the end of 2025, a 1.3% increase from 2024, and a 67.4% increase since 2023.

Over the last 2 years, CeriBell's book value per share changed from -21.16 in 2023 to 4.19 in 2025.


Related Companies

Financial statements for NASDAQ:CBLL last updated on 11/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The Democrats can’t stop this
Porter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypass...
Porter & Company | Sponsoredtc pixel
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
Elon wants to move AI off the planet. Amazon isn't ready.
What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...
StocksToTrade | Sponsoredtc pixel
Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...
Monument Traders Alliance | Sponsoredtc pixel